Guest guest Posted November 8, 2010 Report Share Posted November 8, 2010 2010 AASLD Conference News At Medscape Conference NewsAASLD Short-Course Telaprevir Equal to Full-Course in Some Patients With HCVMedscape Medical News, November 8, 2010AASLD Telbivudine Prevents HBV Perinatal TransmissionMedscape Medical News, November 8, 2010AASLD Abnormal Liver Histology in HIV-Positive Patients Is Cause for ConcernMedscape Medical News, November 8, 2010AASLD Extended Follow-Up of HALT-C Study Shows Some Benefit of InterferonMedscape Medical News, November 7, 2010AASLD Drug Combination Demonstrates Proof of Concept in Controlling HCV Medscape Medical News, November 4, 2010AASLD More Evidence Coffee May Slow Liver DiseaseReuters Health Information, November 4, 2010AASLD Liver Graft Quality Significantly Poorer With Female Vs Male DonorsReuters Health Information, November 4, 2010AASLD Metformin, Vitamin E Do Not Significantly Improve NAFLD in Children Medscape Medical News, November 4, 2010AASLD Black Patients Fare Well on New Hepatitis C Drug TelaprevirReuters Health Information, November 2, 2010AASLD Twelve-Week Interim Analysis of HCV Protease Inhibitor Danoprevir is PositiveMedscape Medical News, November 1, 2010 http://Hepatitis Cnewdrugs.blogspot.com/2010/11/2010-aasld-conference-news-at-medscape.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.